Akebia Therapeutics | AKBA - Capitale Di Prestito

Prezzo Delle Azioni
1.42
Cambio Giornaliero
0 0%
Mensile
14.52%
Annuale
-30.39%
Q1 Previsione
1.38




Capitale Di Prestito Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Akebia Therapeutics USD 48.25M 609K 2025-12
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Amgen USD 50B 2.43B 2025-12
Ardelyx USD 202.83M 696K 2025-12
Astellas Pharma JPY 320B 0 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Bayer EUR 31.83B 877M 2025-12
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Celltrion KRW 63.29B 4.01B 2025-09
Cspc Pharmaceutical CNY 158.75M 102.62M 2025-06
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Fresenius Medical Care EUR 4.85B 4.49B 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 39.44B 30M 2025-12
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Karyopharm Therapeutics USD -0.93 0.67 2024-12
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Lexicon Pharmaceuticals USD 49.41M 7.1M 2025-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Moderna USD 610M 584M 2025-12
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Organigram Holdings CAD 62.52M 13.88M 2025-12
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 36.68M 1.07M 2025-12
Prothena USD 0 0 2024-12
PTC Therapeutics USD 2.03B 193.22M 2025-12
Qiagen NV USD 1.65B 15.23M 2025-12
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Sartorius EUR 3.41B 682.5M 2025-09
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tectonic Therapeutic USD 43K 57K 2025-12
Tilray USD 268.59M 3.82M 2025-09
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 186.56M 9.75M 2025-09